UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 
Date of Report (Date of earliest event reported):  June 4, 2010
 
THE DOW CHEMICAL COMPANY
(Exact name of Registrant as specified in its charter)
 
Delaware
(State or other jurisdiction
of incorporation)
1-3433
Commission File Number
38-1285128
(IRS Employer
Identification No.)

2030 Dow Center, Midland, Michigan
(Address of principal executive offices)
48674
(Zip code)

(989) 636-1000
(Registrant’s telephone number, including area code)
 
N.A.
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
 
Item 8.01.
Other Events.

On June 4, 2010, The Dow Chemical Company (the “Company”) entered into a $3.0 billion Three Year Competitive Advance and Revolving Credit Facility Agreement (the “Revolving Credit Agreement”) with the banks party thereto and Citibank, N.A., as administrative agent for the banks.  The Revolving Credit Agreement contains, among other provisions, covenants and default provisions that are substantially the same as those contained in the Company’s prior revolving credit facility agreement, including the covenant to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time when the aggregate outstanding amount of loans under the Revolving Credit Agreement exceeds $500.0 million.
 
 
 
 
 
 
 
 
 
 
  
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated:  June 10, 2010
 
 
  The Dow Chemical Company  
         
         
  By:  /s/ Ronald C. Edmonds  
    Name: 
Ronald C. Edmonds
  
    Title: 
Vice President and Controller